Marksans Pharma Limited has informed the Exchange regarding a press release dated May 26, 2026, titled ""Marksans Pharma Marksans Pharma Hits Historic Triple: Highest Revenue, EBITDA & PAT ₹3,000 Cr Net Income Guidance Delivered"".